TBPH: Theravance Biopharma Inc

TBPH新闻

• 13:30 TBPH Meets Q2 Earnings Estimates, to be Acquired by Zymeworks
• 23:10 electroCore, Inc. (ECOR) Reports Q2 Loss, Tops Revenue Estimates
• 11:50 Stevanato Group (STVN) Q2 Earnings Top Estimates
• 12:10 Ocular Therapeutix (OCUL) Reports Q2 Loss, Beats Revenue Estimates
• 21:15 Neurocrine Biosciences (NBIX) Surpasses Q2 Earnings and Revenue Estimates
• 12:30 Here’s Why Zymeworks Inc. Paid $929M For Theravance Biopharma (NASDAQ:ZYME)
• 12:54 Theravance Stock Down 3% After Zymeworks Announces Buyout
• 11:48 Silence Therapeutics (SLN) Surges 26.0%: Is This an Indication of Further Gains?
• 13:27 Are Options Traders Betting on a Big Move in Theravance Biopharma Stock?
• 17:26 TBPH Q1 Earnings Beat Amid Strategic Restructuring & Pipeline Hurdle
• 13:50 Here's Why Theravance Biopharma (TBPH) is a Strong Momentum Stock
• 21:10 Xencor (XNCR) Reports Q1 Loss, Lags Revenue Estimates
• 15:15 CORT Q1 Earnings Match Estimates, Revenues Miss, 2026 Outlook Raised
• 12:00 Theravance Biopharma: A Special Situation With A 50-100% Likely Upside (TBPH)
• 17:13 Theravance Stock Declines Around 17% in Three Months: Here's Why
• 13:50 Here's Why Theravance Biopharma (TBPH) is a Strong Momentum Stock
• 15:10 Zacks Industry Outlook Highlights Indivior Pharmaceuticals, Catalyst Pharmaceuticals, Theravance Biopharma, Relmada Therapeutics and Avalo Therapeutics
• 14:00 5 Small Drug Stocks to Buy as Sector Recovery Gains Strength
• 18:45 Theravance's Q4 Earnings and Revenues Miss Estimates
• 16:00 All You Need to Know About Theravance Bio (TBPH) Rating Upgrade to Strong Buy
• 13:45 Here's Why Theravance Biopharma (TBPH) is a Strong Growth Stock
• 13:40 Theravance Biopharma (TBPH) Q4 Earnings and Revenues Lag Estimates
• 21:20 Assertio (ASRT) Reports Q4 Loss, Beats Revenue Estimates
• 13:35 Down 33.7% in 4 Weeks, Here's Why You Should You Buy the Dip in Theravance Bio (TBPH)